ACM
HZNP

Anfield Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Anfield Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-705
Closed -$80.2K – 95
2022
Q4 		$80.2K Sell
705
-1,242
-64% -$141K 0.04% 72
2022
Q3 		$120K Buy
1,947
+60
+3% +$3.7K 0.06% 76
2022
Q2 		$151K Buy
1,887
+445
+31% +$35.6K 0.07% 76
2022
Q1 		$152K Buy
+1,442
New +$152K 0.06% 79